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Adeno-associated viruses (AAVs) are nonpatho-
genic, nonenveloped, single-stranded DNA viruses
in development as gene therapy vectors. AAV inter-
nalization was postulated to proceed via a dynamin-
dependent endocytic mechanism. Revisiting this, we
find that infectious endocytosis of the prototypical
AAV, AAV2, is independent of clathrin, caveolin,
and dynamin. AAV2 infection is sensitive to EIPA, a
fluid-phase uptake inhibitor, but is unaffected by
Rac1 mutants or other macropinocytosis inhibitors.
In contrast, AAV2 infection requires actin cytoskel-
eton remodeling and membrane cholesterol and
is sensitive to inhibition of Cdc42, Arf1, and GRAF1,
factors known to be involved in the formation of
clathrin-independent carriers (CLIC). AAV2 virions
are internalized in the detergent-resistant GPI-
anchored-protein-enriched endosomal compart-
ment (GEEC) and translocated to the Golgi appa-
ratus, similarly to the CLIC/GEEC marker cholera
toxin B. Our results indicate that—unlike the viral
entry mechanisms described so far—AAV2 uses the
pleiomorphic CLIC/GEECpathway as itsmajor endo-
cytic infection route.
INTRODUCTION
Adeno-associated viruses (AAVs) are nonenveloped, single-
stranded DNA viruses of the family Parvoviridae and the genus
Dependovirus that are not associated with any known disease
and show great potential as gene transfer vectors. AAVs depend
on coinfection with a helper virus, such as adenovirus, herpes-
virus, or papillomavirus for productive replication (Grimm and
Kay, 2003). So far, 13 distinct AAV serotypes and more than
100 variants isolated from primates have been described (Daya
and Berns, 2008). The AAV serotypes show distinct transduction
efficiencies and tissue tropism both in vitro and in vivo. This vari-
ability is in part a result of the diversity of AAV surface receptors,
but other evidence suggests that the nature of the endocytic
pathway taken by the virus is also critical for a successful trans-
duction (Bhrigu and Trempe, 2009; Hansen et al., 2000).
Several studies have suggested that recombinant AAV2
internalization proceeds via a dynamin-dependent mechanismCell Host &(Bartlett et al., 2000; Duan et al., 1999) and, based on rapid
uptake kinetics and partial colocalization with endocytosed
transferrin, it was postulated that AAV2 is endocytosed via cla-
thrin-coated vesicles. Interestingly, inhibition of dynamin could
only partially block virus endocytosis, indicating that AAV2 can
use alternative entry routes (Duan et al., 1999). Another study
suggested that AAV2 internalization was dependent on the
GTPase Rac1 (Sanlioglu et al., 2000), which is a major effector
of macropinocytosis, a bulk fluid-phase endocytic mechanism
that is independent of clathrin and dynamin (Doherty and McMa-
hon, 2009).
Here, we revisit the internalization mechanism of recombinant
AAV2 vectors (rAAV2, herein referred to as AAV2) into highly
permissive HeLa and HEK293T cells, using methods specifically
designed to minimize potential postentry effects of pharmaco-
logical inhibitors or recombinant proteins. Because infection
with wild-type AAV can be measured only in the presence of
a helper virus, which would render the analysis of AAV2 endocy-
tosis difficult—if not impossible—we use recombinant AAV2
carrying reporter genes instead of wild-type virus and use the
terms infection and transduction interchangeably. We found
that AAV2 infection occurs independently of clathrin, caveolin,
and dynamin, and that AAV2 infection is sensitive to the amilor-
ide derivative EIPA but does not display other characteristics of
macropinocytosis. In contrast, infectious entry of AAV2 is depen-
dent on an intact actin cytoskeleton and membrane cholesterol
and is sensitive to inhibition of the three main effectors of the
clathrin-independent carriers/GPI-anchored-protein-enriched
endosomal compartment (CLIC/GEEC) pathway—namely
GRAF1 (Lundmark et al., 2008), Cdc42 (Sabharanjak et al.,
2002), and Arf1 (Kumari and Mayor, 2008). AAV2 colocalizes
with internalized GPI-GFP and the cholera toxin B subunit
(CtxB) in early endosomal vesicles and is subsequently trans-
ported to the Golgi apparatus together with CtxB. Interestingly,
a fraction of AAV2 is internalized via a dynamin-dependent
pathway, but this population does not play a major role in infec-
tion. Taken together, our results indicate that—unlike any other
virus studied so far—AAV2 uses the CLIC/GEEC endocytic
pathway as a major infectious entry route.RESULTS
AAV2 Infection Is Independent of Clathrin, Caveolin,
and Dynamin
AAVs contain a single-stranded DNA genome and require
conversion to double-stranded DNA for gene expression. This
essential step is rate limiting and can be influenced by genomicMicrobe 10, 563–576, December 15, 2011 ª2011 Elsevier Inc. 563
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Figure 1. AAV2 Transduction Is Clathrin-, Caveolin-, and Dynamin-Independent
(A) Left panel: AAV2-cherry transduction of HeLa and 293T cells transfected with EGFP-Eps15D95/295, as analyzed by flow cytometry. Transfected cells (GFP+)
were gated, and the fraction of transduced cells among transfected cells (GFP+/mCherry+) was measured. Values are normalized to vector-transfected cells.
Right panel: HeLa cells transfected with EGFP-Eps15D95/295 (green) were exposed to fluorescent transferrin (red) for 15 min and observed by wide-field
fluorescent microscopy with a 633 objective. Transfected cells are outlined in white. Scale bar, 10 mm.
(B) HeLa cells were infected with AAV2-luc in the presence or absence of chlorpromazine (CPZ, 20 mM). Luciferase activity (black bars) was normalized to
untreated control cells. Fluorescent transferrin uptake (white bars and right panels) was quantified by microscopy image analysis as described in Experimental
Procedures.
(C) AAV2 transduction (left) and uptake of cholera toxin B (right; CtxB, red) by HeLa cells expressing dominant negative EGFP-caveolin1 (Cav1DN, green). Cells
were exposed to Alexa 555-cholera toxinB (CtxB) for 1 hr. Scale bar, 10 mm.
(D) Flow cytometry analysis of AAV2-cherry transduction of HeLa and 293T cells transfected with EGFP-Dyn2K44Amutant. Analysis was performed as described
in Figure 1A. Right panel: transferrin uptake (red) in HeLa cells transfected with EGFP-Dyn2K44A (green).
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Infectious Entry of AAV2 via CLIC/GEEC Endocytosisstress and other undefined factors (Ferrari et al., 1996). To rule
out any potential effect of pharmacological inhibitors or ectopic
protein expression on viral DNA second-strand synthesis, we
used a recombinant AAV2 carrying a self-complementary
mCherry cassette. This AAV vector does not depend on comple-
mentary strand synthesis for transgene expression (Wang et al.,
2003). For some experiments, we used a recombinant AAV2
carrying a single-stranded luciferase cassette. These vectors
are referred to as AAV2-cherry and AAV2-luc respectively.
We first investigated whether clathrin- or caveolae-mediated
endocytosis is involved in AAV2 transduction. Clathrin-mediated
endocytosis can be blocked by overexpression of a truncation
mutant of Eps15, a component of clathrin-coated vesicles
(Benmerah et al., 1999). As shown in Figure 1A, AAV2-cherry
transduction—measured by flow cytometry—was completely
unaffected by expression of GFP-tagged Eps15D95/295
(Eps15DN), whereas transferrin internalization was dramatically
decreased. To confirm independently that AAV2 transduction
is not dependent on clathrin-mediated endocytosis, cells were
infected in the presence of chlorpromazine, a known inhibitor
of clathrin-coated pit assembly (Wang et al., 1993). Chlorproma-
zine treatment did not reduce AAV2 transduction of HeLa cells,
while transferrin uptake was inhibited by approximately 75%
under the same conditions (Figure 1B). To minimize drug toxicity
and to prevent pleiotropic effects on postentry steps of infection
(e.g., endosomal escape or viral DNA synthesis), the virus was
stripped from the cell surface by heparin treatment 30 min after
the onset of endocytosis, and cells were then incubated
overnight in drug-free medium to allow transgene expression.
This procedure, which allows the removal of up to 99% of
surface-bound AAV2 (Figure S1), was used in all our studies
involving pharmacological inhibitors. Under the conditions
used, none of our inhibitors caused significant toxicity.
Next, we investigated the role of caveolae-mediated endocy-
tosis in AAV2 transduction. To block caveolar endocytosis, we
expressed caveolin-1 N-terminally fused to EGFP (Cav1DN),
known to act as a dominant-negative mutant (Pelkmans et al.,
2001). Cav1DN expression reduced the uptake of CtxB, amarker
of caveolar endocytosis (Parton et al., 1994), by 50%, but did
not affect AAV2 transduction (Figure 1C). Clathrin- and caveo-
lae-mediated endocytosis are both dynamin-dependent, but
dynamin is also involved in phagocytosis, flotillin-dependent
endocytosis, and interleukin receptor 2-b endocytosis (Doherty
andMcMahon, 2009). Hence, we reinvestigated the role of dyna-
min in AAV2 transduction. Inhibition of dynamin-2 function by the
dominant-negative mutant Dyn2K44A efficiently blocked trans-
ferrin endocytosis but had little or no effect on AAV2 transduction
in either HeLa or 293T cells (Figure 1D); instead, AAV2 transduc-
tion was slightly increased in 293T cells expressing Dyn2K44A
(+25%) (Figure 1D). We also investigated the effect of dynasore,
a potent and reversible dynamin inhibitor (Macia et al., 2006). We
observed an almost complete inhibition of transferrin uptake in
HeLa cells treated with 80 mM dynasore (Figure 1E), while(E) AAV2-Luc uptake in HeLa and 293T cells treated with 80 mM dynasore. Viral D
cells. Right panels, transferrin uptake in HeLa cells treated with 80 mM dynasore
(F) AAV2-luc transduction of HeLa and 293T cells treated with 80 mM dynasore.
(G) Adenovirus type 5-luciferase (Ad5-luc) transduction of HeLa cells in the prese
control cells. Error bars indicate SD, *p < 0.05, **p < 0.005. Because the values ar
Cell Host &AAV2 uptake was unchanged in 293T cells and only moderately
affected in HeLa cells under the same conditions (Figure 1E).
Strikingly, dynasore had no effect on AAV2 transduction in
HeLa cells and stimulated (+60%) transduction in 293T cells (Fig-
ure 1F). In contrast, infection of HeLa cells by a recombinant
adenovirus type 5 vector carrying a luciferase transgene (Ad5-
Luc) was reduced by 65%–70% following dynasore treatment
(Figure 1G), which is consistent with previous studies showing
that Ad5 entry occurs in clathrin-coated pits and requires dyna-
min (Meier and Greber, 2003). Together, these data demonstrate
that although dynamin may contribute to AAV2 internalization to
some extent, it is not strictly required for AAV2 infection.
AAV2 Infection Is Sensitive to EIPA but Does
Not Involve Macropinocytosis
The above findings indicate that the infectious entry of AAV2
occurs mainly through a dynamin-independent pathway. Pre-
vious studies reported that AAV2 endocytosis is Rac1-depen-
dent (Sanlioglu et al., 2000), which would be consistent with
AAV2 being endocytosed bymacropinocytosis, a dynamin-inde-
pendent endocytic mechanism mediating fluid-phase uptake
(Ridley and Hall, 1992). Expression of the dominant-negative
mutant Rac1T17N (Rac1DN) efficiently blocked internalization
of 70 kDa dextran, a fluid-phase marker specific for macropino-
cytosis, but showed little effect onAAV2uptake inHeLacells (Fig-
ure 2A). Similarly, inhibition of Rac1 did not significantly reduce
transduction by AAV2-cherry or AAV2-Luc in 293T cells but
dramatically blocked transduction by Ad5 vectors (Figures 2B
and 2C), which was expected, since Ad5 internalization is
Rac1-dependent (Meier and Greber, 2003). Flow cytometry
confirmed these results; no significant inhibition of AAV2 trans-
duction by Rac1DN in either HeLa or 293T cells was observed
(Figure 2D), whereas constitutively active Rac1 (Rac1Q61L)
slightly decreased transduction in both cell lines. We also tested
several chemical inhibitors of macropinocytosis: 5-(N-Ethyl-N-
isopropyl) amiloride (EIPA), an inhibitor of Na+/H+ exchange;
LY294002, a phosphoinositide-3 kinase (PI3K) inhibitor; IPA-3,
a Pak1 inhibitor; and EHT1864, a Rac1 inhibitor. Only EIPA
inhibited AAV2 transduction (Figure 2E, left panel), whereas all
compounds efficiently blocked macropinocytic uptake of
70 kDa dextran (Figure 2E, right panel). EIPA reduced AAV2 entry
by 50% in 293T cells but not in HeLa cells (Figure 2F). A hallmark
of viruses that are internalized by macropinocytosis or other
Rac1-dependent mechanisms is that they trigger a robust
increase of fluid-phase uptake (Mercer and Helenius, 2009). In
HeLa cells, 70 kDa dextran uptake was strongly enhanced by
incubation with Ad5 at a moi of 105 virions/cell (5-fold) and by
PMA (3-fold), a phorbol ester known to increase macropinocyto-
sis (Swanson, 1989), but was not affected by incubationwith high
amounts of AAV2 (105 genome-containing particles (gcp) per cell)
(Figure 2G). Similarly, 293T cells exposed to AAV2 did not inter-
nalize the fluid-phase markers 70 kDa dextran, 10 kDa dextran,
or Lucifer yellow more efficiently than uninfected control cellsNA was quantified by qPCR. Values are normalized to DMSO-treated control
. Scale bar, 10 mm.
Luciferase values were normalized to DMSO-treated control cells.
nce of 80 mM dynasore. Luciferase values were normalized to DMSO-treated
e normalized to control cells, values in this and other figures can exceed 100%.
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Figure 2. AAV2 Transduction Does Not Involve Macropinocytosis
(A) HeLa cells expressing EGFP-tagged dominant negative Rac1 (Rac1DN, green) were assayed for 70 kDa dextran or AAV2 (red) endocytosis. Transfected cells
are outlined in white. Scale bar, 10 mm.
(B) AAV2-cherry and Ad5-cherry transduction of 293T cells expressing EGFP-Rac1DN. Transfection efficiency was approximately 90% (not shown). Low-
magnification micrographs were acquired with a 53 objective. Values indicate mean red fluorescence intensity per microscope field. Scale bar, 100 mm.
(C) AAV2-luc and Ad5-luc transduction of 293T cells expressing EGFP-Rac1DN. Values are normalized to EGFP vector controls.
(D) Flow cytometry analysis of AAV2-cherry transduction in HeLa and 293T cells expressing EGFP-Rac1DN or EGFP-Rac1CA (constitutively active). Values are
normalized to EGFP-expressing controls.
(E) AAV2-luc transduction (left panel) and fluorescent 70 kDa dextran internalization (right panel) in cells treated with EIPA (a fluid-phase endocytosis inhibitor),
LY294002 (a PI3K inhibitor), IPA-3 (a PAK1 inhibitor), or EHT1864 (a Rac1 inhibitor).
(F) AAV2-luc uptake in cells treated with EIPA. Values are normalized to DMSO-treated cells.
(G) Dextran uptake in HeLa cells incubated with AAV2-luc (105 gcp/cell), PMA (1 mM), or Ad5 (105 gcp/cell). Mean fluorescence values are normalized to DMSO-
treated control. Scale bar, 10 mm.
(H) Flow cytometry analysis of 293T cells incubated for 30minwith fluorescent 70 kDa dextran, 10 kDa dextran, or lucifer yellow (LY) in the absence or presence of
AAV2-luc (105 gcp/cell). Error bars indicate SD, *p < 0.05, **p < 0.005. NS, Not Significant.
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Figure 3. AAV2 Entry and Transduction Involve the Actin Cytoskeleton and Membrane Cholesterol
(A) Surface morphology and actin remodeling of HeLa cells exposed to AAV2-luc (105 gcp/cell, lower panels) or mock-treated (upper panels) for 1 hr on ice and
then transferred to 37C for 10 min. Cells were visualized by scanning electron microscopy (SEM, left panels). Actin cytoskeleton was observed by phalloidin
staining (right panels). Scale bar, 10 mm.
(B) AAV2 binding, uptake, and transduction in HeLa and 293T cells treated with cytochalasin D or jasplakinolide. Values are normalized to DMSO-treated control
cells (represented by dashed lines).
(C) Resistance of AAV2 to triton extraction. HeLa cells incubated with fluorescent transferrin and AAV2-luc for 30 min were subjected to Triton X-100 extraction
and stained for AAV2 capsids. Right panel: quantification of red (transferrin) and green (AAV2) fluorescence (arbitrary units) was performed from three inde-
pendent samples.
(D) Sucrose density fractionation of Triton X-100 extracts fromHeLa (H) and 293T (T) cells incubatedwith AAV2 and biotin-transferrin for 30min at 37C. Viral DNA
recovered from each fraction was quantified by qPCR. Endogenous flotillin1 was detected by dot blot from the same fractions. Control Ad5-luc fractionation
(lower panel) was obtained from a separate sample of 293T cells.
(E) AAV2-luc transduction and endocytosis in HeLa cells treated with methyl-b-cyclodextrin or filipin III. Values are normalized to DMSO-treated control cells.
Error bars indicate SD, *p < 0.05, **p < 0.005.
Cell Host & Microbe
Infectious Entry of AAV2 via CLIC/GEEC Endocytosis(Figure 2H). Overall, these results indicate that, while AAV2 infec-
tion is EIPA-sensitive, it does not occur via macropinocytosis.
AAV2 Infection Is Dependent on Actin and Cholesterol
Several dynamin-independent endocytic mechanisms involve
actin cytoskeleton dynamics and cholesterol-rich detergent-Cell Host &resistant microdomains in order to alter plasma membrane
morphology or trigger vesicle scission (Doherty and McMahon,
2009). Exposure of HeLa cells to high titers of AAV2 (105 gcp/
cell) induced extensive remodeling of the plasma membrane,
including blebbing and filopodia extension (Figure 3A, left
panels), as well as profound modifications of the actinMicrobe 10, 563–576, December 15, 2011 ª2011 Elsevier Inc. 567
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Figure 4. AAV2 Infection Requires Arf1 and Cdc42
(A) AAV2-cherry transduction of HeLa and 293T cells expressing EGFP-tagged Arf1 dominant-negative (DN) and constitutively active (CA) mutants. Flow
cytometry analysis was performed as described in Figure 1A. Insets represent the selected EGFP+/mCherry+ populations, and numbers indicate the percentage
of mCherry+ cells among the EGFP+ population.
(B) AAV2-cherry transduction of HeLa and 293T cells expressing EGFP-tagged Cdc42 DN and CA mutants; analysis as described above.
(C) AAV2-luc transduction of 293T cells expressing dominant-negative Arf1 or Cdc42. Values are normalized to GFP vector-transfected controls.
(D) AAV2 binding and endocytosis in 293T cells transfected with dominant-negative Arf1 or Cdc42. Transfection efficiency was approximately 80% (not shown).
(E) Colocalization of Cdc42 with AAV2 or Ad5 in HeLa cells. Cells were transfected with EGFP-Cdc42WT, infected with AAV2-luc or Ad5-luc, and stained for AAV2
or Ad5 capsids. Insets show higher magnification of boxed areas. Values indicate the percentage of virus (red) overlapping with Cdc42 (green). Scale bar, 20 mm.
(F) CtxB internalization (30 min) in HeLa cells treated with 100 mM EIPA, 80 mM dynasore, or both. Surface-bound CtxB was removed by acid-stripping for
intracellular fluorescence quantification.
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Infectious Entry of AAV2 via CLIC/GEEC Endocytosiscytoskeleton, as shown by phalloidin staining (Figure 3A, right
panels). When actin polymerization or depolymerization was
prevented by treatment with cytochalasin D and jasplakinolide,
respectively, we observed a significant decrease in AAV2 endo-
cytosis and transduction in both HeLa and 293T cells, whereas
virus binding was unaffected or enhanced (Figure 3B). We next
sought to determine whether membrane cholesterol and lipid
raft microdomains are necessary for AAV2 infection. Most inter-
nalized AAV2 was resistant to cold triton extraction on live cells,
while fluorescent transferrin was almost completely extracted
(Figure 3C), which strongly suggests that internalized AAV2
particles are associated with cholesterol-rich detergent-resis-
tant membranes (DRMs). Consistently, in sucrose density gradi-
ents with triton cell lysates, AAV2 was mostly recovered from the
low-density fractions enriched in the lipid raft marker flotillin1. In
contrast, transferrin and adenovirus 5 sedimented in triton-
soluble fractions, which is consistent with internalization in vesi-
cles derived from clathrin-coated pits (Figure 3D). As expected
for a lipid-raft-dependent pathway, AAV2 transduction and
internalization were significantly reduced in HeLa cells treated
with methyl-b-cyclodextrin or filipin III (Figure 3E). These studies
could not be extended to 293T cells because both drugs induced
rapid cell detachment, but the cholesterol synthesis inhibitor
pravastatin reduced infection by 40% in both cell lines (data
not shown). Overall, these results show that both actin and
membrane cholesterol are necessary for AAV2 uptake and that
AAV2 virions are internalized into a detergent-resistant endocytic
compartment.
AAV2 Infection Involves Effectors of the CLIC/GEEC
Pathway
The above results indicate that AAV2 infectious entry is mostly
independent of dynamin and macropinocytosis and requires
actin and cholesterol microdomains. These features are reminis-
cent of the recently characterized CLIC/GEEC pathway, which
mediates uptake of GPI-anchored proteins, fluid-phasemarkers,
and CtxB (Doherty and McMahon, 2009). CLIC/GEEC endocy-
tosis is regulated by Arf1 and Cdc42 GTPases (Chadda et al.,
2007; Kumari and Mayor, 2008), which promote membrane
curvature and local actin polymerization, respectively. CLIC/
GEEC endocytosis is also critically dependent on the Rho
GTPase-activating protein GRAF1 (GTPase Regulator Associ-
ated with Focal Adhesion Kinase) for the tubulation and scission
of CLIC vesicles (Doherty and Lundmark, 2009; Lundmark et al.,
2008). We first investigated the role of Arf1 and Cdc42 proteins in
AAV2 transduction and entry. Dominant-negative mutants of
Arf1 (Arf1T31N) and Cdc42 (Cdc42T17N) significantly reduced
AAV2-cherry transduction in both HeLa and 293T cells, as
measured by flow cytometry (Figures 4A and 4B). Interestingly,
the constitutively active form of Arf1 (Arf1Q71L) also blocked
AAV2 transduction, whereas constitutively active Cdc42
(Cdc42G12V) had no effect (Figures 4A and 4B). AAV2-luc trans-
duction of 293T cells was also reduced by 60% and 70% in 293T
cells expressing Cdc42DN or Arf1DN, respectively (Figure 4C).(G) Confocal micrographs of HeLa cells treated as above. Acid wash was omitted
Scale bar, 10 mM.
(H) Synergistic effect of EIPA and dynasore on AAV2-luc transduction (left panel)
bars indicate SD, *p < 0.05, **p < 0.005.
Cell Host &Both Arf1DN and Cdc42DN inhibited AAV2 uptake (70% reduc-
tion) (Figure 4D), which strongly suggests that both proteins are
directly involved in viral entry. Subcellular localization analysis
using GFP-tagged Cdc42 showed that a large proportion of
incoming AAV2 virions (40%–50% pixel overlap) colocalize
with Cdc42-positive peripheral endocytic structures at early
time points (Figure 4E, left panel). At later time points (40 min),
colocalization could still be observed to some extent (30%
overlap), mostly in perinuclear structures. In contrast, Ad5 virions
showed no significant overlap with Cdc42-labeled structures
(Figure 4E). Cdc42 activity is blocked by amiloride (Koivusalo
et al., 2010). Because we previously observed that the amilor-
ide-derivative EIPA inhibits AAV2 transduction (Figure 2E), we
investigated the effect of EIPA on the internalization of cholera
toxin B, which is internalized via both CLIC endosomes and
caveolae (Howes et al., 2010; Kirkham et al., 2005; Sabharanjak
et al., 2002). EIPA reduced CtxB endocytosis by 50% in HeLa
cells, and CtxB that was internalized in the presence of EIPA
was restricted to peripheral vesicles instead of being transported
to the perinuclear area (Figures 4F and 4G). Strikingly, inhibition
of caveolar endocytosis by dynasore did not affect CtxB uptake,
but simultaneous treatment with both dynasore and EIPA almost
completely abolished CtxB internalization (Figures 4F and 4G),
which is consistent with EIPA being a potent inhibitor of CLIC/
GEEC endocytosis. Similarly, EIPA and dynasore showed
a strong synergistic effect on AAV2 transduction and endocy-
tosis (Figure 4H), which suggests: (1) that AAV2 can enter cells
via two distinct endocytic pathways, dynamin-dependent endo-
cytosis and CLIC/GEEC endocytosis; and (2) that only CLIC/
GEEC endocytosis leads to efficient infection.
We next investigated the role of GRAF1 in AAV2 infection.
Ectopic expression of the dominant negative truncation mutant
GRAF1D384–814 (Lundmark et al., 2008) led to a 30% and
60% reduction in AAV2-cherry transduction in HeLa and 293T
cells, respectively (Figure 5A). GRAF1DN expression also
reduced AAV2-Luc transgene expression in 293T cells, but
conversely increasedAd5-Luc transduction by2-fold (Figure 5B),
showing that GRAF1DN selectively modulates the AAV2 infec-
tious pathway. GRAF1DN expression also inhibited AAV2 uptake
in 293T cells (60% inhibition), which confirms that GRAF1
directly regulates AAV2 endocytosis (Figure 5C). To confirm
further the role of GRAF1 in AAV2 infection, we depleted endog-
enous GRAF1 with small interfering RNA (siRNA). Transfection
with two distinct siRNAs (Lundmark et al., 2008) efficiently
reduced GRAF1 expression in HeLa and 293T cells (Figure S2)
and dramatically decreased AAV2 transduction (Figures 5D
and 5E). Again, GRAF1 knockdown specifically modulated
the AAV2 infectious pathway, since Ad5 transduction was
not decreased in GRAF1-depleted cells (Figure 5F). GRAF1
knockdown efficiently inhibited AAV2 entry in 293T cells (50%
reduction) and to a lesser extent in HeLa cells (20% reduction)
(Figure 5G). This effect was greatly enhanced by dynasore treat-
ment in both cell types (80% reduction), confirming the existence
of two AAV2 endocytic pathways that are dependent on GRAF1to show surface accumulation of CtxB in cells treated with dynasore and EIPA.
and internalization (right panel). Values are normalized to DMSO controls. Error
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Figure 5. AAV2 Infection is GRAF1-Dependent
(A) Transduction of HeLa and 293T cells expressing EGFP-tagged dominant negative GRAF1. Flow cytometry analysis was performed as described in Figures 1A
and 4A.
(B) AAV2-luc and Ad5-luc transduction of 293T cells expressing GFP-GRAF1DN. Values are normalized to EGFP vector control.
(C) Binding and endocytosis of AAV2 in 293T cells expressing GFP-GRAF1DN. Values are normalized to EGFP vector control.
(D) AAV2-cherry and Ad5-cherry transduction of 293T cells following GRAF1 knockdown by siRNA. Numbers indicate mean red fluorescence of pictured
low-magnification microscope fields. Similar results were obtained with HeLa cells (not shown). Scale bar, 100 mm.
(E and F) AAV2-luc (E) and Ad5-luc (F) transduction of HeLa and 293T cells following GRAF1 knockdown by siRNA-A or siRNA-B. Values are normalized to
scrambled siRNA controls (scr).
(G) AAV2-luc endocytosis in HeLa and 293T cells transfected with GRAF1 siRNA with or without dynasore treatment. Values are normalized to scrambled siRNA/
DMSO controls.
(H) Confocal microscopy localization of GFP-GRAF1 (green) with AAV2 or Ad5 virions (red) in HeLa cells. Insets show highermagnifications of boxed areas. Values
indicate the percentage of virus (red) overlapping with GRAF1 (green). Scale bar, 10 mm. Error bars indicate SD, *p < 0.05, **p < 0.005.
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Infectious Entry of AAV2 via CLIC/GEEC Endocytosisand dynamin, respectively. At early time points, confocal micros-
copy showed extensive colocalization of GFP-GRAF1 with inter-
nalized AAV2 virions (>47% overlap), but not with Ad5 virions
(0.9%). As observed with Cdc42, the extent of colocalization
diminished rapidly, since only 20% overlap was observed
40 min after the onset of AAV2 endocytosis (Figure 5H). Overall,
the data indicate that AAV2 infectious entry occurs via CLIC/
GEEC endocytosis, although a fraction of virions are internalized
through dynamin-dependent endocytosis, which does not result
in efficient infection.
AAV2 Internalization and Trafficking
via CLIC/GEEC Endosomes
We next investigated whether internalized AAV2 virions accumu-
late in the same endosomal structures as the prototypical CLIC
cargos, CtxB and GPI-anchored proteins. AAV2 colocalized to
a large extent with CtxB (Figures 6A and 6B) and internalized gly-
cosylphosphatidyl-inositol (GPI)-anchored GFP (Figure 6C),
labeled with a fluorescent anti-GFP antibody (Figure 6C). Coloc-
alization with CtxB and GFP-GPI was stable over time (Fig-
ure 6A–6C), which suggests that AAV2 follows the same
trafficking route as CtxB and GFP-GPI from the plasma
membrane to the perinuclear region. Consistently, AAV2 virions,
but not Ad5 virions, could be recovered from GPI- and GRAF1-
positive membranes purified by immunoisolation with an
anti-GFP antibody (Figure 6D). In sucrose gradients, both GFP-
GRAF1 and GFP-GPI were highly enriched in the same
low-density fractions as AAV2 (Figure 6E), and GFP-GRAF1
immunoisolation performed on pooled DRM fractions confirmed
that AAV2 particles were physically associated with GRAF1-
enriched vesicles in lipid rafts (Figure 6F).
The GEEC pathway involves rapid acidification of endocytic
vacuoles (Kalia et al., 2006), so we evaluated the impact of modi-
fying the endosomal pH on AAV2 transduction. As previously
reported (Bartlett et al., 2000; Douar et al., 2001), bafilomycin
A1, an inhibitor of endosome acidification, completely blocked
AAV2 transduction when the drug was added within 1 hr after
the onset of endocytosis (Figure S3). Consistent with previous
studies (Johnson et al., 2010; Pajusola et al., 2002), AAV2 virions
rapidly trafficked to the Golgi apparatus, showing > 30% coloc-
alization with the Golgi marker giantin 2 hr postinfection (Fig-
ure 7A and 7B). Brefeldin A, a drug causing Golgi disassembly,
dramatically inhibited AAV2 transduction (Figure 7C). These
results are consistent with a role for Golgi transport in AAV2
infection, although we can not exclude other effects of brefeldin
A on different parts of the endosomal system. AAV2 trafficking to
the Golgi was unaffected in cells treated with dynasore but was
reduced more than 10-fold following EIPA treatment (Figure 7D).
Similarly, AAV2 transport to the Golgi was strongly impaired in
cells overexpressing dominant negative mutants of GRAF1
(6-fold), Cdc42 (10-fold) or Arf1 (7-fold) (Figure 7D).
Taken together, our findings indicate that AAV2 internalization
into CLIC/GEEC endosomes is necessary for efficient trafficking
and infection.
DISCUSSION
In this report, we demonstrate that AAV2 infectious entry in HeLa
and 293T cells has all the hallmarks of CLIC/GEEC endocytosis:Cell Host &It is functionally dependent of GRAF1, Cdc42, Arf1, the actin
cytoskeleton, and membrane cholesterol, and internalized
virions accumulate in endocytic vesicles enriched in CLIC/
GEEC markers such as CtxB, GPI-anchored proteins, and
GRAF1. AAV2 is unique in its ability to use the CLIC/GEEC
pathway as a route of infectious entry. We found that AAV2
transduction does not require clathrin, caveolin, or dynamin,
which was unexpected because previous reports suggested
that inhibition of dynamin reduces viral transduction by approx-
imately 50% (Duan et al., 1999; Ren et al., 2007). Notably,
these experiments relied on adenoviral vectors for overexpres-
sion of dominant negative dynamin (dynamin K44A), and it is
now well established that adenovirus or adenoviral vectors
induce dramatic changes in cell homeostasis that may pro-
foundly affect AAV2 trafficking (Johnson et al., 2010; Xiao
et al., 2002).
AAV2 infectious entry is sensitive to EIPA but does not depend
onmacropinocytosis. EIPA reduced CtxB uptake, and this effect
was drastically increased when caveolar uptake of CtxB was
blocked by dynamin inhibition. These results are in agreement
with recent reports showing that amiloride inhibits Cdc42 activity
(Koivusalo et al., 2010) and, hence, likely reduces constitutive
endocytosis of GPI-anchored proteins (Cortese et al., 2008;
Tkachenko et al., 2004) through the CLIC/GEEC pathway. Inhibi-
tion of both CLIC/GEEC- and dynamin-dependent endocytosis
was required to block completely AAV2 entry (Figure 4), which
indicates that AAV2 can enter cells simultaneously via dyna-
min-dependent and -independent mechanisms. Our results
indicate that the route of AAV2 endocytosis determines the
fate of internalized virions and the efficiency of infection; appar-
ently only CLIC/GEEC-mediated entry leads to efficient trans-
duction, presumably due to increased trafficking of AAV2 virions
to theGolgi apparatus (Figure 7). The retrograde transport mech-
anism leading to Golgi accumulation of AAV2 is largely unknown.
We did not observe extensive virion accumulation in early, late,
or recycling endosomes labeled with Rab5, Rab7, or Rab11,
respectively (data not shown), suggesting that AAV2 might
bypass the classical endosomal system to reach the Golgi appa-
ratus, although we cannot rigorously exclude a role of these
proteins in AAV infection, even in the absence of significant
colocalization. In contrast, AAV2 and CtxB accumulated in the
same transport intermediates from the plasma membrane to
the Golgi (Figure 6A), which is reminiscent of previous studies
showing that GPI-anchored proteins and CtxB are transported
to the Golgi in carriers devoid of classical endosome markers
(Nichols, 2002; Nichols et al., 2001).
Interestingly, a recent high-throughput siRNA study performed
on human aortic endothelial cells showed that AAV2 transduc-
tion was strongly inhibited (from 3-fold to 15-fold) following
siRNA knockdown of GRAF1, Arf1, or ARHGAP10, another
CLIC/GEEC effector (Wallen et al., 2011). These observations
suggest that our findings are likely valid in other cell types,
including primary cells. To our knowledge, virus entry via CLIC/
GEEC endocytosis has not been described so far. However,
the characterization of other viral endocytic pathways has shown
that viruses are able to take advantage of every available cellular
internalization mechanism (Sieczkarski andWhittaker, 2002) and
that they frequently use more than one route. The CLIC/GEEC
system is a high-capacity, constitutive, and pleiotropicMicrobe 10, 563–576, December 15, 2011 ª2011 Elsevier Inc. 571
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Figure 6. Colocalization of AAV2 with Cholera Toxin B and GFP-GPI
(A) Confocal microscopy localization of AAV2 (green) with fluorescent Cholera toxin B (red). Insets show higher magnifications of boxed areas.
(B) Quantification of AAV2/CtxB colocalization in (A). Values indicate the percentage of AAV2 (green) overlapping with CtxB (red).
(C) HeLa cells transfected with GFP-GPI (green) were incubated 30 min on ice with AAV2 (purple) and Alexa 555-conjugated anti-GFP polyclonal antibody (red),
washed, and transferred to 37C for the indicated times. After removal of surface labeling by PI-PLC and heparin, internalized AAV2 capsids were stained with
A20 followed by a Cy5 secondary antibody. Insets show higher magnifications of boxed areas. Values show the percentage of AAV2 (purple) overlapping with
internalized anti-GFP antibody (red). Scale bar, 10 mm.
(D)Quantification ofAAV2orAd5genomes inGPI- orGRAF1-enrichedvesiclespurifiedby immunoisolation. 293Tcells transfectedwithGFP-taggedGPIorGRAF1
were infected with AAV2-luc or Ad5-luc (104 gcp/cell) and whole cell lysates were immunoprecipitated with an anti-GFP antibody as described in Experimental
Procedures. AAV2 and Ad5 DNA recovered from immunoisolates were quantified by qPCR. Values are normalized to the total viral DNA in each cell lysate.
(E) Sucrose density fractionation of GFP-GRAF1 andGFP-GPI in transfected 293T cells. GFP-GPI fractions were obtained from a different sample. The fractions 4
and 5 (boxed) were used for the immunoisolation experiments in (F).
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Infectious Entry of AAV2 via CLIC/GEEC Endocytosisendocytic mechanism that can lead to the internalization of the
complete plasma membrane of a fibroblast in about 15 min
(Howes et al., 2010). Thus, clathrin-independent carriers may
constitute an attractive and potent entry mechanism for viruses
and other pathogens. In addition, CLIC endosomes are highly
acidic (Kalia et al., 2006), which creates a favorable environment
for capsid or envelope modifications necessary for subsequent
trafficking/sorting steps of many viruses, including AAV2 (Fig-
ure S3 and Bartlett et al., 2000). Intriguingly, several viruses
show similarities with AAV2 in their mode of entry. Human papil-
lomavirus type 16, lymphocytic choriomeningitis virus, and influ-
enza virus have all been associated with endocytic mechanisms
independent of clathrin, caveolin, or macropinocytosis (Mercer
et al., 2010), and simian virus 40 (SV40) can use a cholesterol-
dependent, dynamin-independent pathway (Damm et al.,
2005). In Cav1/ cells SV40 internalization occurs in noncoated
tubular vesicles (Ewers et al., 2010) similar to those formed by
GRAF1 in vitro and in vivo (Lundmark et al., 2008). Other viruses
have been documented to bind to GPI-anchored proteins as
their attachment receptors, such as enterovirus 70 and echo-
virus with the decay-accelerating factor (Lakhan et al., 2009).
In light of our results, it will be interesting to investigate whether
the CLIC/GEEC pathway is a more general mode of viral
endocytosis.
EXPERIMENTAL PROCEDURES
Materials
All commercially available reagents, plasmids, and the sequences of primers
and siRNAs used in this study are described in Supplemental Information.
Cells, Transfection, siRNA, and Viruses
HEK293T and HeLa cells (ATCC, Manassas, VA) were maintained in DMEM
with 10% FBS (Sigma, St. Louis), L-glutamine, and antibiotics. 293T cells
were transfected by calcium phosphate precipitation. HeLa cells were trans-
fected with GeneJammer (Agilent, Santa Clara, CA) or Lipofectamine 2000
(Invitrogen, Carlsbad, CA). Stealth siRNAs (Table S1) were from Invitrogen
and were transfected with Lipofectamine 2000. Recombinant AAV2 was
produced and purified as previously described (Gigout et al., 2005; Grimm
et al., 1998; Hirosue et al., 2007; Zolotukhin et al., 1999). Viral titers were deter-
mined by real-time PCR with transgene-specific primers (Table S1). Adeno-
virus type 5 (Ad5) vectors carrying the mCherry or luciferase transgene were
kindly provided by Kleopatra Rapti and Lifan Liang (Mount Sinai School of
Medicine, NY).
Viral Transduction Assays
For experiments involving chemical inhibitors, cells pretreated with inhibitors
for 30 min were infected for 30–60 min at 37C with AAV2 or Ad5 carrying
the mCherry or luciferase transgene. Surface AAV2 was stripped with
100 mg/ml heparin for 10 min in the presence of drugs. Ad5 was removed by
acid wash in DMEM, 25 mM sodium acetate (pH 2.0) for 2 min on ice. Cells
were then incubated overnight in drug-free medium. Luciferase activity was
measured with Promega Luciferase Assay System in a Wallac luminometer
(PerkinElmer, San Jose, CA). Values were normalized to the total protein
content of the lysates, measured by BCA assay. All pharmacological inhibitors
were also tested with AAV2-cherry with similar results (data not shown). For
experiments involving recombinant protein expression, cells were infected
24 hr posttransfection, incubated for 16–24 hr and assayed for fluorescence
by flow cytometry or microscopy, or for luciferase activity.(F) Immunoisolation of GRAF1-enriched endosomal vesicles from lipid rafts. Imm
raft fractions 4 and 5 (highlighted in red) with an anti-GFP antibody (GRAF1 IP) or w
the immunoprecipitates were quantified by qPCR. Values were normalized to the
Error bars indicate SD, **p < 0.005.
Cell Host &Virus Binding and Endocytosis Assays
For binding studies, virus was added for 1 hr on ice before PBS wash. Cells
were lysed in 1% NP-40 buffer, and DNA was extracted using Zyppy plasmid
miniprep columns (Zymo Research, Orange, CA) with a 10 min incubation at
95C in lysis buffer to denature viral capsids. Viral DNA was quantified by
real-time quantitative PCR (qPCR) using Clontech SYBR green mix with trans-
gene-specific primers.
For AAV2 endocytosis studies, cells were infected for 1 hr at 37C, then
heparin was added for 10 min to remove surface-bound virus. Cells were tryp-
sinized and low-molecular weight DNA was extracted. Viral genomes were
quantified by qPCR with luciferase primers and are referred to as ‘‘internalized
AAV genomes.’’
Endocytosis Assays with Endocytic Markers
Cells incubated on ice with fluorescent transferrin (20 mg/ml), cholera toxin
(1 mg/ml), dextran (1 mg/ml), or lucifer yellow (1 mg/ml) were transferred to
37C for the indicated times. Endocytosis was stopped by ice-cold PBS
washes, and surface-bound dyes were removed by acid treatment for 2 min
on ice in DMEM, 25mM sodium acetate (pH 2.0). Fluorescence wasmeasured
by microscopy as the average fluorescence of three different fields (approxi-
mately 200 cells per field) from three separate samples and quantified with
Photoshop software (Adobe). For GPI internalization, cells expressing GFP-
GPI were incubated with Alexa 555-conjugated anti-GFP antibody (1:400 dilu-
tion) on ice, washed, and transferred to 37C. Surface-bound antibody could
be stripped by removal of GFP-GPI with 0.5 U of PI-PLC (Invitrogen) for
30 min at 4C (>95% surface fluorescence removal; data not shown). The
anti-GFP antibody was highly specific since no labeling of untransfected
neighboring cells was observed.
Immunofluorescence
HeLa cells plated on glass coverslips were fixed in 4%PFA in PBS for 15min at
room temperature, permeabilized with 0.2% Triton X-100 and blocked for 1 hr
with 0.5% BSA in PBS. For experiments using EIPA, cells were fixed in cold
methanol for 5 min at 20C. After incubation with primary antibodies (over-
night at 4C) and fluorescent secondary antibodies (1 hr at room temperature),
nuclei were counterstained with DAPI, and slides were mounted in Mowiol and
observed with a Leica SP5 DM confocal microscope. All confocal images
represent a single plane acquired with a 633 oil objective and a pinhole set
at 1 Airy unit (optical slice 0.8 mm). Quantification of colocalization was per-
formed on three separate fields and in at least two independent experiments
using the Metamorph software.
Scanning Electron Microscopy
Cells grown on coverslips were incubated 1 hr on ice with ssLuc AAV2
(105 gcp/cell) and transferred to 37C for 10 min. Cells were fixed in 3% glutar-
aldehyde for 30 min, postfixed in 1% OsO4 (4C, 30 min), dehydrated in
ethanol, critical point dried, coated with palladium-gold, and observed with
a Hitachi S4300 field emission scanning electron microscope.
Triton Extraction, Cell Fractionation, and Immunoisolation
Triton extraction of HeLa cells grown on coverslips was performed as previ-
ously described (Nichols et al., 2001) after infection with AAV2 (105 gcp/cell)
for 30 min in the presence of fluorescent transferrin. For sucrose fractionation,
cells grown in 150 mm plates were infected for 1 hr with AAV2 or Ad5 (104 gcp/
cell). Biotinylated transferrin (5 mg/ml) was used as a marker of nonlipid raft
membranes. Cell lysis and sucrose density gradient fractionation were per-
formed as previously described (Legler et al., 2005). Viral DNA was extracted
from each fraction with Zyppy columns and quantified by qPCR. For immunoi-
solation of GRAF1 and GFP-GPI-containing membranes, 293T cells trans-
fected with GFP-GPI or GFP-GRAF1 were lysed and scraped on ice in buffer
containing 1% Triton X-100, 150 mM NaCl, 50 mM Tris (pH 7.5), and protease
inhibitors (2ml buffer per 15 cmplate). Lysateswere precleared 1 hr at 4Cwith
agarose-protein G beads (50 ml beads per 2 ml lysate) and incubated for 1hr atunoprecipitations were performed from whole cell lysate (WCL) or pooled lipid
ith normal mouse serum as a negative control (ctrl IP). Viral genomes present in
total amount of viral DNA in the whole lysate or in the pooled fractions 4 and 5.
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Figure 7. Postentry Trafficking of AAV2
(A) Confocal microscopy localization of AAV2 (green) and the Golgi marker giantin (red). Insets show higher magnifications of boxed areas. Scale bar, 20 mm.
(B) Quantification of AAV2/Golgi colocalization. Values indicate the percentage of AAV2 (green) overlapping with giantin (red). Mean fluorescence intensity of total
internalized AAV2 is shown as a dotted line.
(C) AAV2 transduction and uptake in HeLa cells treated with brefeldin A (BFA). Values are normalized to DMSO controls.
(D) Confocal microscopy localization of AAV2 (red) and Golgi (anti-giantin, Cy5 pseudocolored in blue) in HeLa cells treated with dynasore, EIPA, or transfected
with dominant-negative GRAF1, Cdc42, or Arf1 (green). Values in the graph indicate the percentage of AAV2 (red) overlapping with giantin (blue). Nuclei were
stained with DAPI and pseudocolored in grayscale. Scale bar, 10 mm. Error bars indicate SD, **p < 0.005.
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Infectious Entry of AAV2 via CLIC/GEEC Endocytosis4Cwith 35 ml agarose-protein G beads coated with 2 mg anti-GFP antibody in
lysis buffer with 1% BSA. Following extensive washes in lysis buffer/BSA,
beads were suspended in PBS, and DNA was extracted with Zyppy columns.
Normal mouse serum was used as immunoprecipitation control.
Statistical Analysis
Data are representative of at least three independent experiments, and values
are given as mean of triplicates ± standard deviation (SD). Statistical signifi-
cance is determined by paired Student’s t test. Only p values % 0.05 were
considered statistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures, one table, Supplemental
Experimental Procedures, and Supplemental References and can be found
online with this article at doi:10.1016/j.chom.2011.10.014.
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